Literature DB >> 6871464

Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues.

R Lorenzet, G Peri, D Locati, P Allavena, M Colucci, N Semeraro, A Mantovani, M B Donati.   

Abstract

This study investigated the procoagulant activity (PCA) of mononuclear phagocytes from rabbits bearing the V2 carcinoma. Macrophages harvested from either intraperitoneally or subcutaneously growing tumors were found to express a very strong procoagulant activity as compared with peritoneal macrophages and circulating mononuclear cells from the same animals. On the other hand, when incubated with or without endotoxin in short-term cultures, circulating mononuclear cells from tumor-bearing animals generated significantly more procoagulant activity than those from control animals. In all instances, procoagulant activity was identified as tissue factor by using assay systems with plasmas selectively deficient in the various clotting factors. These results indicate that, besides cancer cells, mononuclear phagocytes might also play an important role in the activation of blood coagulation and in the deposition of fibrin at the host-tumor interface.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871464

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.

Authors:  R Lorenzet; J Niemetz; A J Marcus; M J Broekman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Development and validation of an assay for urinary tissue factor activity.

Authors:  B A Lwaleed; M Chisholm; J L Francis
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets.

Authors:  A Di Santo; C Amore; G Dell'Elba; S Manarini; V Evangelista
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

Review 5.  Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

Authors:  M Shoji; W W Hancock; K Abe; C Micko; K A Casper; R M Baine; J N Wilcox; I Danave; D L Dillehay; E Matthews; J Contrino; J H Morrissey; S Gordon; T S Edgington; B Kudryk; D L Kreutzer; F R Rickles
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 6.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

7.  Recalcification time in breast disease.

Authors:  C A Sofia; C R Spillert; J A Pastena; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

Review 8.  Pathogenesis of thrombosis in patients with malignancy.

Authors:  A Falanga; M B Donati
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

9.  Whole blood procoagulant activity in breast and colorectal cancer.

Authors:  H Mellor; I Taylor; S Roath; J L Francis
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

10.  Flow cytometric analysis of tissue factor (TF) expression on stimulated monocytes--comparison to procoagulant activity of mononuclear blood cells.

Authors:  T Luther; C Flössel; V Hietschhold; R Koslowski; M Müller
Journal:  Blut       Date:  1990-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.